01 1Extrovis AG
01 1MONOBASIC POTASSIUM PHOSPHATE
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-03-28
Pay. Date : 2025-03-07
DMF Number : 38689
Submission : 2023-08-08
Status : Active
Type : II
20
Extrovis Ag, based in Switzerland, is a pharmaceutical company.
They are recognized for Extrovis's success lies in improving healthcare through innovation.
One of their notable products is MONOBASIC POTASSIUM PHOSPHATE, with a corresponding US DMF Number 38689.
Remarkably, this DMF maintains an Active status since its submission on August 08, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 28, 2025, and payment made on March 07, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
